Wall Street Zen cut shares of Guardian Pharmacy Services (NYSE:GRDN – Free Report) from a buy rating to a hold rating in a research report report published on Saturday,Wall Street Zen reports.
A number of other research analysts have also recently commented on GRDN. Oppenheimer increased their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Truist Financial upped their price objective on Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Weiss Ratings raised Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Finally, Bank of America upped their target price on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $44.50.
Guardian Pharmacy Services Price Performance
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The firm had revenue of $351.77 million for the quarter, compared to analysts’ expectations of $340.45 million. On average, research analysts expect that Guardian Pharmacy Services will post 1.19 EPS for the current fiscal year.
Institutional Investors Weigh In On Guardian Pharmacy Services
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Jennison Associates LLC raised its stake in shares of Guardian Pharmacy Services by 609.5% during the first quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after acquiring an additional 706,823 shares during the last quarter. Braun Stacey Associates Inc. purchased a new stake in shares of Guardian Pharmacy Services during the second quarter worth about $14,234,000. Ranger Investment Management L.P. bought a new stake in shares of Guardian Pharmacy Services in the second quarter worth about $7,263,000. Dimensional Fund Advisors LP increased its holdings in Guardian Pharmacy Services by 200.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock valued at $7,855,000 after purchasing an additional 139,070 shares during the period. Finally, Sei Investments Co. increased its holdings in Guardian Pharmacy Services by 40.5% during the 1st quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock valued at $13,489,000 after purchasing an additional 103,177 shares during the period.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.
The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.
Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.
Featured Stories
- Five stocks we like better than Guardian Pharmacy Services
- Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
- Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
- AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
- Insiders Signal Deep Value In DICK’s Sporting Goods
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
